The concept of immune privilege is receiving renewed attention followi
ng the identification of Fas ligand (FasL)-mediated apoptosis as a pro
tective mechanism in this biological phenomenon. Once perceived as a p
assive process relying on physical barriers and isolation, immune priv
ilege can now be viewed as an active phenomenon employing an important
natural process to maintain organ integrity.